Product Information
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.1846 per EA under NDC 00480329556. Its NADAC has been published 49 times since Sep 17, 2025.
FDA first approved this application on Jun 25, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15; 92 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480329556
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA204982FDA Approved
6/25/2024
TE Code
AB
On Market Since
5/7/2025
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has been published 49 times since Sep 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1846 per EA |
|---|---|
| All-time high | $3.7531 (Mar 11, 2026) |
| All-time low | $3.1437 (Sep 17, 2025) |
| 52-week high | $3.7531 |
| 52-week low | $3.1437 |
| Median price | $3.4861 |
| Average price | $3.4729 |
| Largest weekly change | +6.7% (Dec 17, 2025) |
| Weeks tracked | 49 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Phentermine and topiramate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $3.1846 per EA (NDC 00480329556), effective Aug 19, 2026.
How has the price of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
Since Sep 17, 2025, the NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has ranged from a low of $3.1437 (Sep 17, 2025) to a high of $3.7531 (Mar 11, 2026), with a median of $3.4861 per EA.
Are there cheaper alternatives to PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE (NDC 00480329556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.